FDA Approved: DIPENTUM — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

The FDA approved a supplemental application for DIPENTUM (olsalazine sodium) submitted by Viatris Specialty LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• DIPENTUM (olsalazine sodium)

Snippet

SUPPL AP for DIPENTUM (OLSALAZINE SODIUM)